Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Operating Leases (2019 - 2025)

Historic Operating Leases for OptimizeRx (OPRX) over the last 7 years, with Q3 2025 value amounting to $507000.0.

  • OptimizeRx's Operating Leases rose 1601.83% to $507000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $507000.0, marking a year-over-year increase of 1601.83%. This contributed to the annual value of $209000.0 for FY2024, which is 4366.58% down from last year.
  • OptimizeRx's Operating Leases amounted to $507000.0 in Q3 2025, which was up 1601.83% from $548000.0 recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Operating Leases ranged from a high of $548000.0 in Q2 2025 and a low of $14019.0 during Q2 2023
  • Its 5-year average for Operating Leases is $277380.6, with a median of $260614.0 in 2021.
  • Per our database at Business Quant, OptimizeRx's Operating Leases crashed by 9261.39% in 2023 and then surged by 338812.33% in 2024.
  • Over the past 5 years, OptimizeRx's Operating Leases (Quarter) stood at $236726.0 in 2021, then tumbled by 38.95% to $144532.0 in 2022, then skyrocketed by 156.69% to $371000.0 in 2023, then tumbled by 43.67% to $209000.0 in 2024, then soared by 142.58% to $507000.0 in 2025.
  • Its last three reported values are $507000.0 in Q3 2025, $548000.0 for Q2 2025, and $310000.0 during Q1 2025.